Feature | July 15, 2011| Dave Fornell

Intra-Cardiac Echo Aids EP Ablations, Structural Heart Procedures

Users say ICE offers more versatile imaging than TEE and will play a key role in transcatheter valve replacements

Catheter-based intra-cardiac echocardiography (ICE) is an imaging modality similar to intra-vascular ultrasound (IVUS). It allows imaging inside the heart to visualize cardiac structures and blood flow using Doppler imaging. The standard-of-care for this type of imaging is usually transesophageal echo (TEE), but ICE proponents say the intra-cardiac modality has several advantages.


The image quality is comparable to TEE, but the real advantage is the cardiologist controls the catheter instead of a sonographer, eliminating a second operator, explains Jay Lee, medical director of electophysiology (EP) at Hoag Heart and Vascular Institute, Newport Beach, Calif. He said ICE also provides more versatility than the limited view provided by TEE, because the catheter can be maneuvered to see more inside the heart and the aortic root. Unlike TEE, ICE does not require general anesthesia.


ICE has applications for structural heart imaging of the left atrial appendage (LAA), to aid in septal defect closures and visualizing the fossa ovalis, and plays a role in transcatheter valve replacement. It also is used in EP procedures for ablation catheter guidance.


EP Guidance
Lee primarily uses ICE for transcatheter EP ablations to treat atrial fibrillation (aFib), ventricular tachycardias and the pulmonary vein. In EP transcatheter ablation procedures, ICE confirms the exact location of the catheter tip to aid with more accurate ablations. ICE also can  help with safety monitoring of the pericardial space for tamponade or pericardial effusion caused in rare cases by either the transeptal puncture or the ablation, Lee said.


“It’s a wonderful tool to help us guide our procedures more accurately,” Lee said. “We also have found some new areas for ICE in the EP lab…I find it very useful with access and safety. We also find it useful for treating ventricular tachycardias.”
Hoag uses the Carto EP mapping system, which is compatible with Siemens’ ICE system. GE, Boston Scientific and St. Jude also offer ICE systems.


“It’s very practical when we are performing aFib catheterizations, because it offers real-time imaging of the heart,” Lee said.
He uses a transeptal puncture to feed the imaging catheter into the atrium he is ablating. Lee says a transeptal puncture is safer than other entry options, and used the ICE catheter to visualize exactly where the transeptal puncture is made.
The ICE system is used to create a map of the pulmonary artery and the atriums, and can help create a 3-D map of the ventricular anatomy, including details of the papillary muscles.  


ICE Catheters
Single element rotational (also referred to as radial) imaging catheters offer a similar view as IVUS and are good for close-up, near-field imaging, Lee said. Phased array ICE catheters allow side-fire, wedge-shaped images that are similar to conventional ultrasound imaging. Lee said phased array catheters offer better far-field imaging.


From his experience, Lee said rotational imaging offers about 2 cm field-of-view (FOV) of clear imaging (Boston Scientific says its system images up to 14 cm), which is good for the septum and the fossa ovalis. But due to the limited FOV, he said most EP labs will find phased array systems more useful, with vendors claiming imaging depths of up to 30 cm.


Boston Scientific’s Ultra ICE system uses radial ICE imaging, which is not steerable and is limited to 2-D imaging. The Siemens, GE and St. Jude systems are steerable and offer 2-D, color and spectral Doppler capabilities.


These catheters cost a couple thousand dollars each, which has led to resistance to widespread adoption, Lee said.


The Future of ICE
Lee said ICE works in tandem with EP mapping systems now, but further integration in the future will lead to more procedural accuracy. Mapping systems can import computed tomography (CT) images to use as a map of the heart, but the image is not in real time. Lee expects future systems to allow registration of the echo image with the mapping system for live imaging.


ICE is expected to become increasingly important to better guide an increasing number of transcatheter ablation procedures. Once transcatheter aortic and mitral valve heart valve replacement and LAA occlusion devices gain U.S. Food and Drug Administration (FDA) clearance, ICE is expected to see increased use for the accurate deployment of these devices.   
 

Related Content

Sponsored Content | Videos | Inventory Management| September 21, 2016
With bundled payments putting increased pressure on hospitals to manage supply costs while providing quality patient
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
don woodlock, GE Healthcare, EP CVIS, electrophyiology
Sponsored Content | Webinar | Cardiac PACS| September 16, 2016
Cardiac rhythm management (CRM) data is becoming increasingly important in the management of patients with implantabl
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
Sponsored Content | Videos | Heart Failure| September 02, 2016
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by res
Respicardia, Remede, pacemaker for sleep apnea, central sleep apnea treatment

The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.

News | Heart Failure| September 02, 2016
September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator significa
News | Cardiac Resynchronization Therapy Devices (CRT)| August 30, 2016
August 30, 2016 — Medtronic plc announced results from the...
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Merlin, Merlin@home, SJM, St. Jude Medical Merlin, cybersecurity

St. Jude Medical said recent claims of the cyber attack vulnerability of its [email protected] remote monitoring system and its implantable EP devices are not true.

Feature | EP Lab| August 29, 2016 | Dave Fornell
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St.
Overlay Init